Table 2 |
|||
|
Baseline characteristics of 24 patients included in the study. |
|||
|
Data, mean (SD) |
r-hGH (n = 12) |
Control (n = 12) |
p value t student test |
|
|
|||
|
Demographics |
|||
|
Age, years |
47,4 (7,6) |
49,6 (9,4) |
0.555 |
|
Weight, kg |
72,9 (12,3) |
66,0 (9,4) |
0.153 |
|
Waist, cm |
89.2 (10.3) |
76.6 (3.2) |
0.01 |
|
BMI, Kg/m2 |
25,1 (5,3) |
162,2 (5,9) |
0.334 |
|
Fibromyalgia symptoms duration (prior study), months |
21 (6) |
23 (7) |
0,204 |
|
Vital signs |
|||
|
Systolic blood pressure, mm Hg |
124,8 (15,4) |
117,5 (10,3) |
0.222 |
|
Diastolic blood pressure, mm Hg |
80,8 (6,6) |
74,2 (7,9) |
0.052 |
|
Heart rate, beats/min |
75,8 (6,4) |
77,9 (11,8) |
0.721 |
|
Laboratory data |
|||
|
GH, ng/mL |
0,4 (0,3) |
0,9 (0,8) |
0.134 |
|
IGF-1 g/L |
173.3 (49.4) |
98.6 (36.0) |
<0.001 |
|
TSH, μU/mL |
1.3 (0.9) |
1.3 (0.9) |
0.998 |
|
free T4, ng/mL |
3.3 (4.9) |
5.5 (6.9) |
0.433 |
|
free T3, pg/mL |
3.7 (0.7) |
2.9 (0.5) |
0.041 |
|
Estradiol E2, pg/mL |
117.8 (17.7) |
98.4 (81.7) |
0.708 |
|
P4, ng/mL |
0.4 (0.3) |
0.7 (0.3) |
0.287 |
|
Urinary free cortisol, μg/24 h |
98.2 (66.1) |
44.5 (11.9) |
0.030 |
|
Insulinemia U/dL |
11.9 (14.7) |
6.0 (2.7) |
0.306 |
|
Apolipoprotein B, mg/L |
102.8 (26.7) |
98.7 (66.1) |
0.744 |
|
C-Reactive protein, mg/L |
3.2 (0.4) |
3.5 (0.0) |
0.417 |
|
Erythrocyte sedimentation rate, mm |
12.8 (5.8) |
11.0 (4.6) |
0.482 |
|
|
|||
|
Cuatrecasas et al. BMC Musculoskeletal Disorders 2007 8:119 doi:10.1186/1471-2474-8-119 |
|||
